Annexon, Inc. (ANNX)
4.50
-0.17
(-3.64%)
USD |
NASDAQ |
Sep 09, 10:31
Annexon Price to Book Value : 4.223 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 4.382 |
| September 04, 2026 | 4.570 |
| September 03, 2026 | 4.542 |
| September 02, 2026 | 4.626 |
| September 01, 2026 | 4.589 |
| August 31, 2026 | 4.636 |
| August 28, 2026 | 4.664 |
| August 27, 2026 | 4.927 |
| August 26, 2026 | 4.683 |
| August 25, 2026 | 4.833 |
| August 24, 2026 | 4.748 |
| August 21, 2026 | 4.758 |
| August 20, 2026 | 4.861 |
| August 19, 2026 | 5.161 |
| August 18, 2026 | 4.955 |
| August 17, 2026 | 4.814 |
| August 14, 2026 | 4.964 |
| August 13, 2026 | 4.936 |
| August 12, 2026 | 5.002 |
| August 11, 2026 | 5.011 |
| August 10, 2026 | 5.058 |
| August 07, 2026 | 5.077 |
| August 06, 2026 | 5.255 |
| August 05, 2026 | 5.039 |
| August 04, 2026 | 5.002 |
| Date | Value |
|---|---|
| August 03, 2026 | 4.927 |
| July 31, 2026 | 4.781 |
| July 30, 2026 | 4.946 |
| July 29, 2026 | 4.561 |
| July 28, 2026 | 4.664 |
| July 27, 2026 | 4.814 |
| July 24, 2026 | 4.899 |
| July 23, 2026 | 4.974 |
| July 22, 2026 | 4.908 |
| July 21, 2026 | 5.058 |
| July 20, 2026 | 5.227 |
| July 17, 2026 | 5.443 |
| July 16, 2026 | 5.527 |
| July 15, 2026 | 6.100 |
| July 14, 2026 | 5.208 |
| July 13, 2026 | 5.283 |
| July 10, 2026 | 5.443 |
| July 09, 2026 | 5.574 |
| July 08, 2026 | 5.593 |
| July 07, 2026 | 6.034 |
| July 06, 2026 | 5.593 |
| July 02, 2026 | 5.124 |
| July 01, 2026 | 5.208 |
| June 30, 2026 | 5.358 |
| June 29, 2026 | 4.425 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Marker Therapeutics, Inc. | 1.754 |
| Krystal Biotech, Inc. | 7.544 |
| Immix Biopharma, Inc. | 4.006 |
| ACADIA Pharmaceuticals, Inc. | 3.658 |
| Alnylam Pharmaceuticals, Inc. | 25.10 |
Price to Book Value Related Metrics
| Price | 4.50 |
| Earnings Yield | -25.50% |
| Market Cap | 785.72M |